Arturo Aguirre

Arturo Aguirre, Ph.D., is an accomplished scientist with extensive experience in analytical research and development within the pharmaceutical industry. Currently serving as Senior Scientist II at AbbVie, since November 2020, Arturo focuses on transitioning compounds from the Discovery Phase to Phase I clinical trials, collaborating with various cross-functional teams. Prior to this role, Arturo held positions as Senior Scientist I at AbbVie and Research Scientist at Regis Technologies, where contributions centered on expediting drug candidates to market. Arturo's academic background includes a Ph.D. in Medicinal and Natural Products Chemistry from the University of Iowa, where research involved overcoming bacterial resistance and analyzing small-molecule inhibitors. Additional experience includes internships at Genentech and Integrated DNA Technologies, concentrating on drug metabolism, pharmacokinetics, and molecular genetics.